Recruiting Patients.
Advancing Research.

A New Research Study for People With Severe Emphysema

The IAB-2 study is a clinical research study designed to gather new information about the safety and effectiveness of implanted Implantable Artificial Bronchus (IAB) devices in people with severe emphysema.

Who May Qualify?

To participate in the IAB-2 study, individuals must meet certain eligibility requirements, including:

  • Have severe emphysema

  • Be 22 years of age or older

  • Have a body mass index (BMI) between 18 and 35

  • Have been smoke-free for at least four months

  • Have had no hospitalization for a COPD exacerbation (flare-up) within the past six weeks, and no more than two such hospitalizations in the past year

  • Not have significant mucus production or chronic bronchitis

  • Not have undergone previous lung volume reduction surgery

Additional eligibility requirements apply. 
Meeting these initial criteria does not guarantee enrollment.

STUDY DETAILS

Participating Research Sites

The IAB-2 study includes the following research centers:

  • Boston, Massachusetts

  • Chicago, Illinois

  • San Francisco, California

  • Milwaukee, Wisconsin

  • Nashville, Tennessee

Interested in Learning More?

For additional information about the IAB-2 study or to refer a patient, please contact Pulmair Medical.

Email: support@Pulmair.com | Phone: (858) 369-0000